What Happened?
San Francisco, CA-based Aeovian-Pharmaceuticals Appointed Stelios Tzannis as President and Chief Executive Officer
About the Company
We are a San Francisco Bay Area-based research stage biopharmaceutical company aiming to discover, develop and commercialize innovative therapeutics for the treatment of rare and age-related diseases. We are developing compounds to modulate molecular pathways that address the underlying causes of disease initiation and progression, such as oxidative, cellular and environmental stress.
About the Person
Stelios Tzannis is President and Chief Executive Officer at Aeovian Pharmaceuticals. Previously, Stelios held various senior HR leadership roles in the industry.
Info Source
News
Short Profile